Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1992 Aug;76(8):457–460. doi: 10.1136/bjo.76.8.457

Immunoimaging of choroidal melanoma: assessment of its diagnostic accuracy and limitations in 101 cases.

J Scheidler 1, G Leinsinger 1, C M Kirsch 1, O F Scheiffarth 1, F H Stefani 1, K G Riedel 1
PMCID: PMC504316  PMID: 1390525

Abstract

Immunoscintigraphy (IS) was performed on 101 patients with space occupying intraocular lesions including choroidal melanomas (85), choroidal naevi (11), non-melanoma metastases (three), and other melanoma simulating lesions (two). Scintigraphic images with conventional and emission computer tomography techniques were obtained after the intravenous injection of 99mTc-labelled F(ab')2 fragments of monoclonal antibody (MoAb) 225.28S directed against the high molecular weight-melanoma associated antigen (HMW-MAA). Immunohistochemistry was performed on sections of four out of 10 melanoma-containing eyes to confirm MoAb binding. IS demonstrated positive scans in 66 out of 85 choroidal melanomas, offering a sensitivity of 78%. Sensitivity was dependent on the lesion size. True negative results were obtained in 15 out of 16 non-melanoma lesions (specificity 94%). False positive antibody accumulation was found in one patient with a post-traumatic subretinal haemorrhage. Immunohistochemistry demonstrated positive MoAb 225.28S binding in all melanoma sections. In summary IS offered substantial sensitivity and specificity in the differentiation of intraocular lesions, particularly choroidal melanomas, naevi, and metastases. In combination with other diagnostic procedures such as ultrasound echography and fluorescein angiography IS proved to be a valuable method in the diagnosis of choroidal melanoma.

Full text

PDF
457

Images in this article

458Image
on p.458
459Image
on p.459

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bomanji J., Garner A., Prasad J., Albert D. M., Hungerford J. L., Granowska M., Britton K. E. Characterisation of ocular melanoma with cutaneous melanoma antibodies. Br J Ophthalmol. 1987 Sep;71(9):647–650. doi: 10.1136/bjo.71.9.647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bomanji J., Hungerford J. L., Granowska M., Britton K. E. Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments. Br J Ophthalmol. 1987 Sep;71(9):651–658. doi: 10.1136/bjo.71.9.651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bomanji J., Hungerford J. L., Granowska M., Britton K. E. Uptake of 99mTc labelled (Fab')2 fragments of monoclonal antibody 225.28S by a benign ocular naevus. Eur J Nucl Med. 1988;14(3):165–166. doi: 10.1007/BF00293543. [DOI] [PubMed] [Google Scholar]
  4. Buraggi G. L. Radioimmunodetection of malignant melanoma with the 225.28S monoclonal antibody to HMW-MAA. Nuklearmedizin. 1986 Dec;25(6):220–224. [PubMed] [Google Scholar]
  5. Chatal J. F., Fumoleau P., Saccavini J. C., Thedrez P., Curtet C., Bianco-Arco A., Chetanneau A., Peltier P., Kremer M., Guillard Y. Immunoscintigraphy of recurrences of gynecologic carcinomas. J Nucl Med. 1987 Dec;28(12):1807–1819. [PubMed] [Google Scholar]
  6. Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., MacDonald S., Pulford K. A., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984 Feb;32(2):219–229. doi: 10.1177/32.2.6198355. [DOI] [PubMed] [Google Scholar]
  7. Damato B. E., Campbell A. M., McGuire B. J., Lee W. R., Foulds W. S. Monoclonal antibodies to uveal melanoma. Eye (Lond) 1987;1(Pt 6):686–690. doi: 10.1038/eye.1987.112. [DOI] [PubMed] [Google Scholar]
  8. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  9. Le Doussal J. M., Martin M., Gautherot E., Delaage M., Barbet J. In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate. J Nucl Med. 1989 Aug;30(8):1358–1366. [PubMed] [Google Scholar]
  10. Liniecki J., Pertyński T., Krawczykowa Z., Stepień J., Durski K. 51Cr-bleomycin in the diagnosis of ocular melanoma. Nuklearmedizin. 1983 Dec;22(6):306–308. [PubMed] [Google Scholar]
  11. Locher J. T., Seybold K., Andres R. Y., Schubiger P. A., Mach J. P., Buchegger F. Imaging of inflammatory and infectious lesions after injection of radioiodinated monoclonal anti-granulocytes antibodies. Nucl Med Commun. 1986 Sep;7(9):659–670. [PubMed] [Google Scholar]
  12. Mach J. P., Chatal J. F., Lumbroso J. D., Buchegger F., Forni M., Ritschard J., Berche C., Douillard J. Y., Carrel S., Herlyn M. Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. Cancer Res. 1983 Nov;43(11):5593–5600. [PubMed] [Google Scholar]
  13. Matzku S., Kirchgessner H., Schmid U., Temponi M., Ferrone S. Melanoma targeting with a cocktail of monoclonal antibodies to distinct determinants of the human HMW-MAA. J Nucl Med. 1989 Mar;30(3):390–397. [PubMed] [Google Scholar]
  14. Ossoinig K. C. Standardized echography: basic principles, clinical applications, and results. Int Ophthalmol Clin. 1979 Winter;19(4):127–210. [PubMed] [Google Scholar]
  15. Rosebrough S. F., Grossman Z. D., McAfee J. G., Kudryk B. J., Subramanian G., Ritter-Hrncirik C. A., Witanowski L. S., Tillapaugh-Fay G., Urrutia E., Zapf-Longo C. Thrombus imaging with indium-111 and iodine-131-labeled fibrin-specific monoclonal antibody and its F(ab')2 and Fab fragments. J Nucl Med. 1988 Jul;29(7):1212–1222. [PubMed] [Google Scholar]
  16. Scheidhauer K., Markl A., Leinsinger G., Moser E., Scheiffarth O. F., Riedel K. G., Schaal T. S., Stefani F. H., Schumacher U. Immunoscintigraphy in intraocular malignant melanoma. Nucl Med Commun. 1988 Sep;9(9):669–678. doi: 10.1097/00006231-198809000-00010. [DOI] [PubMed] [Google Scholar]
  17. Scheiffarth O. F., Strobl J., Stefani F. H., Riedel K. G., Scheidhauer K. Tumormarker beim malignen Aderhautmelanom. Fortschr Ophthalmol. 1989;86(6):639–643. [PubMed] [Google Scholar]
  18. Shields J. A. Accuracy and limitations of the 32P test in the diagnosis of ocular tumors: an analysis of 500 cases. Ophthalmology. 1978 Sep;85(9):950–966. doi: 10.1016/s0161-6420(78)35595-0. [DOI] [PubMed] [Google Scholar]
  19. Siccardi A. G., Buraggi G. L., Callegaro L., Mariani G., Natali P. G., Abbati A., Bestagno M., Caputo V., Mansi L., Masi R. Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma. Cancer Res. 1986 Sep;46(9):4817–4822. [PubMed] [Google Scholar]
  20. Wilson B. S., Imai K., Natali P. G., Ferrone S. Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int J Cancer. 1981 Sep 15;28(3):293–300. doi: 10.1002/ijc.2910280307. [DOI] [PubMed] [Google Scholar]
  21. van der Pol J. P., Jager M. J., de Wolff-Rouendaal D., Ringens P. J., Vennegoor C., Ruiter D. J. Heterogeneous expression of melanoma-associated antigens in uveal melanomas. Curr Eye Res. 1987 Jun;6(6):757–765. doi: 10.3109/02713688709034842. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES